CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.
Conference
"Emerging issues impacting the health outcomes of HIV infected individuals initiating antiretroviral therapy" Dr. Robert Hogg (biography) English - 2002-04-26 - 17 minutes
(18 slides)
Summary : Highly Active Antiretroviral Therapy (HAART) has been shown to dramatically decrease morbidity and mortality in symptomatic and asymptomatic HIV infected individuals. As a result, these antiretroviral drug regimens have been widely adopted for the treatment oh HIV infection. In the past, recommendations for the initiation of antiretroviral therapy were largely based on both CD4 cell count and plasma HIV RNA levels.
Current observational evidence suggests that rates of disease progression to AIDS or death among those on antiretroviral therapy are a function of baseline CD4 cell counts rather than of HIV RNA levels. The aim of this talk is to briefly characterize patterns of antiretroviral usage, changes in rates of morbidity and mortality and salient prognostic factors associated with diseases progression in the province of British Columbia with evidence from other observational studies from around the world. In addition, the potential impact of these findings on current guidelines and on antiretroviral access in region outside North America, Europe and Oceania will be assessed.
Learning objectives : To learn about survival improvements of patients starting ART, data on the time to start ART, data on antiretroviral class, and issues of antiretroviral access worldwide.
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
